Program Leadership
Principle Investigator
Chair, Department of Obstetrics and Gynecology
Research Director
H&H Evergreen Faculty Scholar Director, Perinatal Biology
Recruitment Director
Chief, Stanford Gynecology Service
Advisory Committee
The internal Advisory Committee members are:
The external Advisory Committee members are:
Faculty Mentors by Focus Area
Maternal-Child Health & Epidemiology
Stanford’s Division of Maternal-Fetal Medicine and Obstetrics has an outstanding record of scientific investigation with a particular strength in perinatal epidemiology. The Division leverages unique large-scale databases, including linked data from all California births and nationwide commercial claims data, to generate evidence that informs the care of pregnant and postpartum individuals and their infants. Stanford investigators mentor junior investigators in leading research using these data resources with ample epidemiologic and biostatistical support. The division also leads clinical trials that include multidisciplinary teams and provide experience in trial methodology as well as availability of primary data.
REI and Stem Cell Biology
The Division of Reproductive, Stem Cell and Perinatal Biology is the home for outstanding basic and translational science within the Department of OB/GYN complementing the Divisions of Reproductive Endocrinology and Infertility and Maternal-Fetal Medicine. Current faculty study germ cells, ovarian hormonal regulation, pluripotent stem cells, pre-implantation development, placental development, and related reproductive and obstetrical complications.
Gynecologic Health Across the Lifespan
Gynecologic health across the lifespan is supported by many focus areas in the Division of Gynecology: pediatric and adolescent gynecology, academic generalist OB/GYN, family planning, minimally invasive surgery, female pelvic medicine and reproductive surgery, and menopause and healthy aging. The Division of Gynecology participates in several national clinical trials involving new hormonal therapies for contraception and menopausal replacement as well as studies on vaginal infections. Clinical research focuses on studying pelvic organ prolapse, incontinence and LUTS, genitourinary syndrome of menopause and overactive bladder. We are involved in large, multi-center trials throughout the U.S. as well as physician-initiated trials. Family Planning Services and Research is actively engaged in research relating both to development of new contraceptive methods and innovations in contraceptive programs that will improve access and patient-level success. Research ranges from basic science assessments of reproductive biology to programmatic and population-level assessments of contraceptive knowledge, attitudes, and practices.
Gynecologic Oncology
The Gynecologic Oncology division offers a comprehensive program of basic science, clinical, and translational research in gynecologic cancer, education and outstanding patient care. Laboratory research focuses primarily on ovarian cancer while the clinical and translational research includes the use of new drugs and innovative new therapies, including vaccines and immunotherapy. Collaborative research is ongoing in stem cell biology, new imaging techniques for screening and monitoring disease, and studies of new biomarkers to determine prognosis.
Perinatal Biology
This focus area has a strong group of basic and translational mentors that explore the underlying pathogenesis of preterm birth, preeclampsia, and placenta accreta, as well as investigate the normal physiology of pregnancy focusing on placental development and the immune system. Translational aspects of perinatal genetics are also well represented.
LGBTQ+ Health
Stanford has recently established a Center for Sexual and Gender Medicine (PI Dr. Subak), establishing a unique and comprehensive multidisciplinary program to improve the health and wellbeing of the LGBTQ+ community. A key strength for this focus group is the recent recruitment of Drs. Lunn and Obedin-Maliver, co-founders of The PRIDE Study and PRIDEnet.
Innovative Technology and Precision Health
Stanford Medicine is dedicated to the advancement of precision health through application of innovative discovery. Stanford fosters a “can do” environment that fosters creativity and out of the box thinking. Mentors in this focus area bring cutting edge innovation and greatly enhance the WRHR Program.